MedTrace Logo

The Clinical Effect of Fuke Qianjin Capsule on Chronic Pelvic Pain Caused by Pelvic Inflammation

NCT03251560 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2018-02-05

No results posted yet for this study

Summary

A prospective random control clinical trials to research Fuke Qianjin capsule's effects on ameliorating the pain caused by chronic pelvic disease.

Conditions

  • Chronic Pelvic Pain

Interventions

DRUG

Fuke Qianjin capsule

Fuke Qianjin capsule 0.8g pills by mouth, three times daily

DRUG

Placebo oral capsule

Placebo oral capsule 0.8g pill by mouth, three times daily

Sponsors & Collaborators

  • Second Hospital of Jilin University

    collaborator OTHER

  • Shenzhen maternal and child health care hospital

    collaborator UNKNOWN

  • Guangzhou Women and Children's Medical Center

    collaborator OTHER

  • Aijun Sun

    lead OTHER

Principal Investigators

  • Aijun Sun, MD · Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03251560 on ClinicalTrials.gov